AbCellera Results Presentation Deck slide image

AbCellera Results Presentation Deck

FINANCIALS FULL YEAR 2022 BUSINESS UPDATE COPYRIGHT © ABCELLERA 19 $485.4M total revenue, driven by royalties for bebtelovimab. Revenue USD ROYALTIES MILESTONES LICENSING RESEARCH FEES $375.2M 2021 $485.4M $443.0M $40.8M 2022
View entire presentation